DUBLIN--(BUSINESS WIRE)--The "Peripheral Vascular Devices Market Report, Forecast by Device Type, Country and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
Fluidx Medical Technology, Inc. announced the completion of patient enrollment in the investigational device exemption (IDE) piv ...
Based on type, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous vascular access device, and accessories. Among these, in ...
Midline catheters and vascular access devices (VADs) play a pivotal role in modern clinical practice by offering less invasive alternatives to central venous access. Midline catheters, which are ...
The US Food and Drug Administration is alerting the public of a potentially high-risk device issue related to Rotarex Atherectomy Systems (Bard Peripheral Vascular) used in peripheral artery ...
Inserting, monitoring, and maintaining peripheral venous access is an integral component of neonatal nursing care. Although complications associated with peripheral vascular devices are typically ...
OKLAHOMA CITY--(BUSINESS WIRE)--Linear Health Sciences, a medical device company that has developed a proprietary, breakaway safety valve platform, today announced that the Infusion Nurses Society ...
The U.S. FDA has finalized a guidance for class II devices for treatment of peripheral artery disease that excludes drug-coated balloons (DCBs), which are regulated as class III devices. One of the ...
The vascular delivery (vascular access) device market in Brazil is growing and was valued at nearly $59 million in 2012. Recent growth over is primarily due to the increasing size and age of the ...
Velano Vascular said it has achieved U.S. Food and Drug Administration (FDA) 510(k) clearance for PIVO™, its needle-free vascular access device. The device is meant to allow for ease-of-use and high ...
It is feasible to forgo femoral access and go through the radial artery for many complex lower-extremity interventions, findings from the prospective R2P registry suggest. Across a range of PAD ...